A Study of the Efficacy and Safety of Dulaglutide (LY2189265) in Participants With Type 2 Diabetes
Clinical trial NCT03495102 · COMPLETED
Trial details
- NCT number
- NCT03495102
- Sponsor
- Eli Lilly and Company
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2018-04-05
- Primary completion
- 2019-05-28
- Enrollment
- 1842
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.